Amundi Asset Management US’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-139
Closed -$6K – 1633
2020
Q3
$6K Hold
139
– – ﹤0.01% 1568
2020
Q2
$6K Buy
139
+69
+99% +$2.57K ﹤0.01% 1587
2020
Q1
$3K Sell
70
-1,886
-96% -$107K ﹤0.01% 1582
2019
Q4
$139K Hold
1,956
– – ﹤0.01% 1532
2019
Q3
$146K Hold
1,956
– – ﹤0.01% 1523
2019
Q2
$158K Hold
1,956
– – ﹤0.01% 1511
2019
Q1
$131K Hold
1,956
– – ﹤0.01% 1514
2018
Q4
$146K Hold
1,956
– – ﹤0.01% 1440
2018
Q3
$180K Buy
1,956
+689
+54% +$65.6K ﹤0.01% 1464
2018
Q2
$125K Buy
+1,267
New +$142K ﹤0.01% 1457

Other funds holding CMD

Amundi Asset Management US's CMD Position: Q4 2020 in Review

Amundi Asset Management US sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 139 shares — an estimated $6K sold.

Amundi Asset Management US first reported a position in CMD in Q2 2018 and held it in 10 quarters. The position peaked at $180K in Q3 2018. 230 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Amundi Asset Management US reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 139 Cantel Medical Corporation shares in Q4 2020, an estimated $6K.
  • Amundi Asset Management US first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 10 quarters.
  • Amundi Asset Management US's Cantel Medical Corporation position peaked at $180K in Q3 2018.
  • 230 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.